Point72 Asset Management’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-68
Closed -$198 2750
2023
Q1
$198 Buy
+68
New +$343 ﹤0.01% 2152
2019
Q1
Sell
-378,359
Closed -$7.32M 1223
2018
Q4
$7.32M Buy
378,359
+136,507
+56% +$3M 0.04% 468
2018
Q3
$7.75M Buy
241,852
+211,852
+706% +$6.44M 0.03% 505
2018
Q2
$798K Buy
+30,000
New +$816K ﹤0.01% 850

Other funds holding STIM

Point72 Asset Management's STIM Position: Q2 2023 in Review

Point72 Asset Management sold out of Neuronetics (STIM) in Q2 2023, closing a stake of 68 shares — an estimated $198 sold.

Point72 Asset Management first reported a position in STIM in Q2 2018 and held it in 4 quarters. The position peaked at $7.75M in Q3 2018. 69 funds tracked by Wall St. Rank hold STIM as of Q2 2023.

  • Point72 Asset Management reported no remaining Neuronetics position as of Q2 2023 after selling out during the quarter.
  • Point72 Asset Management sold 68 Neuronetics shares in Q2 2023, an estimated $198.
  • Point72 Asset Management first reported a position in Neuronetics in Q2 2018 and held it in 4 quarters.
  • Point72 Asset Management's Neuronetics position peaked at $7.75M in Q3 2018.
  • 69 funds tracked by Wall St. Rank held Neuronetics as of Q2 2023.

Based on Point72 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.